إعلان
إعلان
DNLI
Denali Therapeutics Inc. Common Stock
16.25
USDبرعاية
-0.26
-1.56%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
16.29
+0.04
+0.23%
تقارير أرباح DNLI
النسبة الإيجابية المفاجئة
DNLI تفوق 15 من 32 آخر التقديرات.
47%
التقرير التالي
بيانات التقرير القادم
٢٥ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.27M
/-$0.76
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+2.70%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+13.43%
Denali Therapeutics Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, DNLI reported earnings of -0.74 USD per share (EPS) for Q3 25, beating the estimate of -0.76 USD, resulting in a 3.51% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.23% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 20 analysts forecast an EPS of -0.76 USD, with revenue projected to reach 1.27 مليون USD, implying an increase of 2.70% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Denali Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Denali Therapeutics Inc. Common Stock reported EPS of -$0.74, beating estimates by 3.51%, and revenue of $0.00, 0% as expectations.
How did the market react to Denali Therapeutics Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 4.23%, changed from $14.41 before the earnings release to $15.02 the day after.
When is Denali Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٥ فبراير ٢٠٢٦.
What are the forecasts for Denali Therapeutics Inc. Common Stock's next earnings report?
Based on 20
analysts, Denali Therapeutics Inc. Common Stock is expected to report EPS of -$0.76 and revenue of $1.27M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان